文献速递心脑血管急症复苏、休克与脓毒症

预测急性肺栓塞早期大出血的原创风险评分:晕厥、贫血、肾功能不全(PE-SARD)出血评分

An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score.
PubMed 文献 · Chest · 2021-07-02
一句话结论PE-SARD评分(晕厥+1.5、贫血+2.5、肾功能不全+1)可简单分层急性肺栓塞患者早期大出血风险,高分者出血率8.93%。

本研究基于多中心前瞻性注册研究的2,754例急性肺栓塞患者,通过事后多变量logistic回归构建预测住院期间大出血的PE-SARD评分,并在推导队列内用bootstrapping(500次迭代)验证。82例(3.0%)发生大出血,独立预测因子为晕厥(+1.5分)、贫血(血红蛋白<12 g/dL,+2.5分)、肾功能不全(GFR<60 mL/min,+1分)。评分0分为低危(52.2%,出血率0.97%),1–2.5分为中危(35.2%),>2.5分为高危(12.6%,出血率8.93%)。C-index 0.74,Brier评分0.028,性能优于VTE-BLEED、RIETE和BACS评分。

要点

  • PE-SARD评分三项预测因子及分值:晕厥+1.5分,贫血(血红蛋白<12 g/dL)+2.5分,肾功能不全(GFR<60 mL/min)+1分。
  • 评分0分为低危组(52.2%,出血率0.97%),1–2.5分为中危组(35.2%),>2.5分为高危组(12.6%,出血率8.93%)。
  • 总体早期大出血发生率3.0%(95%CI 2.39%–3.72%),共82例。
  • 推导队列C-index 0.74(95%CI 0.73–0.76),Brier评分0.028,bootstrapping内部验证结果相似。
  • PE-SARD评分对出血风险的区分性能优于VTE-BLEED、RIETE和BACS评分,并在出血与非出血患者中实现较高比例的风险重分类。

适用人群与场景

  • 来自多中心前瞻性注册研究的2,754例急性肺栓塞患者,用于推导和内部验证早期(至出院)大出血风险评分。

诊断标准与关键阈值

  • PE-SARD评分组成:晕厥+1.5分;贫血(血红蛋白<12 g/dL)+2.5分;肾功能不全(GFR<60 mL/min)+1分;总分为各项之和。
  • 风险分层:0分为低危,1–2.5分为中危,>2.5分为高危。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:多中心前瞻性注册研究的事后多变量logistic回归分析,推导并内部验证(bootstrapping 500次迭代)PE-SARD评分,共纳入2,754例急性肺栓塞患者。
  • 主要终点:早期(至出院)大出血事件82例,发生率3.0%(95%CI 2.39%–3.72%)。
  • 多变量回归识别三个预测因子:晕厥(+1.5分)、贫血(血红蛋白<12 g/dL,+2.5分)、肾功能不全(GFR<60 mL/min,+1分)。
  • 风险分组及观察出血率:低危(0分)52.2%(95%CI 50.29%–54.11%),出血率0.97%(95%CI 0.53%–1.62%);中危(1–2.5分)35.2%(95%CI 33.39%–37.04%);高危(>2.5分)12.6%(95%CI 9.30%–16.56%),出血率8.93%(95%CI 6.15%–12.44%)。
  • 模型性能:推导队列C-index 0.74(95%CI 0.73–0.76),Brier评分0.028;内部bootstrapping验证结果相似。
  • 与VTE-BLEED、RIETE、BACS评分比较,PE-SARD评分性能更好,并在出血与非出血患者中实现较高比例的风险重分类。

证据类型、等级与局限

  • 证据类型:基于多中心前瞻性注册研究的事后分析,推导并内部验证风险评分;原文未报告证据等级或推荐强度。
  • 局限:原文未明确列出局限;设计上为事后分析、内部验证(bootstrapping),未进行外部验证。

对床旁实践的改变

  • PE-SARD评分可用于急性肺栓塞患者早期大出血风险分层:0分者出血风险低(0.97%),>2.5分者出血风险高(8.93%),有助于床旁识别高危患者并优化急性期管理。
  • 评分计算简单(晕厥、贫血、肾功能不全三项),便于急诊/ICU床旁快速应用;但原文未提供基于评分的具体治疗调整方案,需结合临床判断。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Improved prediction of the risk of early major bleeding in pulmonary embolism (PE) is needed to optimize acute management.

RESEARCH QUESTION: Does a simple scoring system predict early major bleeding in acute PE patients, identifying patients with either high or low probability of early major bleeding?

STUDY DESIGN AND METHODS: From a multicenter prospective registry including 2,754 patients, we performed post hoc multivariable logistic regression analysis to build a risk score to predict early (up to hospital discharge) major bleeding events. We validated the endpoint model internally, using bootstrapping in the derivation dataset by sampling with replacement for 500 iterations. Performances of this novel score were compared with that of the VTE-BLEED (Venous Thrombo-Embolism Bleed), RIETE (Registro informatizado de la enfermedad tromboembólica en España; Computerized Registry of Patients with Venous Thromboembolism), and BACS (Bleeding, Age, Cancer, and Syncope) models.

RESULTS: Multivariable regression identified three predictors for the occurrence of 82 major bleeds (3.0%; 95% CI, 2.39%-3.72%): Syncope (+1.5); Anemia, defined as hemoglobin <12 g/dL (+2.5); and Renal Dysfunction, defined as glomerular filtration rate <60 mL/min (+1 point) (SARD). The PE-SARD bleeding score was calculated by summing all the components. Overall, 52.2% (95% CI, 50.29%-54.11%) of patients were classified as low bleeding-risk (score, 0 point), 35.2% (95% CI, 33.39%-37.04%) intermediate-risk (score, 1-2.5 points), and 12.6% (95% CI, 9.30%-16.56%) high-risk (score >2.5 points). Observed bleeding rates increased with increasing risk group, from 0.97% (95% CI, 0.53%-1.62%) in the low-risk to 8.93% (95% CI, 6.15%-12.44%) in the high-risk group. C-index was 0.74 (95% CI, 0.73-0.76) and Brier score 0.028 in the derivation cohort. Similar values were calculated from internal bootstrapping. Performance of the PE-SARD score was better than that observed with the VTE-BLEED, RIETE, and BACS scores, leading to a high proportion of bleeding-risk reclassification in patients who bled and those who did not.

INTERPRETATION: The PE-SARD bleeding risk score is an original, user-friendly score to estimate risk of early major bleeding in patients with acute PE.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Chopard R, Piazza G, Falvo N, et al. An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score. Chest. 2021. PMID: 34217683. doi:10.1016/j.chest.2021.06.048

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。